Cannara Biotech Inc. (TSX:LOVE)

Cannara Biotech Revenue

Cannara Biotech had revenue of 31.83M CAD in the quarter ending May 31, 2026, with 16.45% growth. This brings the company's total for the last twelve months to 117.45M, up 14.66% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth. That makes Cannara Biotech the 24,014th largest company in the world by revenue and 445th in Canada.

• Revenue (ttm): 117.45M
• Revenue Growth: +14.66%
• P/S Ratio: 1.63
• Revenue / Employee: 259.59K
• Employees: 452
• Market Cap: 198.42M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Cannabis Operations 103.02M 96.4%
• Real Estate Operations 3.84M 3.6%

Fiscal year ended Aug 31, 2025 See the full Cannara Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	107.32M	25.17M	30.64%
Aug 31, 2024	82.15M	24.59M	42.71%
Aug 31, 2023	57.56M	21.57M	59.91%
Aug 31, 2022	36.00M	18.73M	108.48%
Aug 31, 2021	17.27M	15.17M	723.42%
Aug 31, 2019	2.10M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error